Synapse - Works

Results (5608)

Nomogram-based prediction of overall survival (OS) of patients (pts) with metastatic urothelial carcinoma (UC) receiving first-line platinum-based chemotherapy: Retrospective international study of invasive/advanced cancer of the urothelium (RISC)

Meeting Abstract

Necchi, A.; Sonpavde, G.; Lo Vullo, S.; Bamias, A.; Crabb, S. J.; Harshman, L.; Bellmunt, J.; De Giorgi, U.; Sternberg, C.; Ladoire, S.; more...
Annals of Oncology (2016)

Fulltext@MSK | Save

Phase III trial of sunitinib (SU) vs placebo (PBO) as adjuvant treatment for high-risk renal cell carcinoma (RCC) after nephrectomy (S-TRAC)

Meeting Abstract

Ravaud, A.; Motzer, R. J.; Pandha, H. S.; Staehler, M.; George, D.; Pantuck, A. J.; Patel, A.; Chang, Y. H.; Escudier, B.; Donskov, F.; more...
Annals of Oncology (2016)

Fulltext@MSK | Save

Anti-tumor activity of PEGylated human IL-10 (AM0010) in renal cancer alone and in combination with anti-PD1

Meeting Abstract

Naing, A.; Papadopoulos, K. P.; Autio, K. A.; Ott, P. A.; Patel, M. R.; Wong, D. J.; Falchook, G.; Pant, S.; Whiteside, M.; Rasco, D.; more...
Annals of Oncology (2016)

Fulltext@MSK | Save

Phase 1 study of the PSMA-targeted tubulysin small-molecule drug conjugate EC1169 in patients with metastatic castrate-resistant prostate cancer (mCRPC): Study update

Meeting Abstract

Morris, M. J.; Vogelzang, N. J.; Sartor, O.; Armour, A.; Petrylak, D.; Tolcher, A.; Ejadi, S.; Babiker, H. M.
Annals of Oncology (2016)

Fulltext@MSK | Save

Phase 3 study of avelumab in combination with axitinib versus sunitinib as first-line treatment for patients with advanced renal cell carcinoma (aRCC)

Meeting Abstract

Motzer, R. J.; Choueiri, T.; Larkin, J.; Albiges, L.; Haanen, J. B.; Schmidinger, M.; Atkins, M. B.; Mariani, M.; Shnaidman, M.; Di Pietro, A.; more...
Annals of Oncology (2016)

Fulltext@MSK | Save

EMBARK: A phase 3, randomized, efficacy and safety study of enzalutamide plus leuprolide, enzalutamide monotherapy and placebo plus leuprolide in men with high-risk nonmetastatic prostate cancer progressing after definitive therapy

Meeting Abstract

Miller, K.; Mulders, P.; Freedland, S. J.; Scher, H.; Shore, N.; Park, E.; Krivoshik, A.; Phung, D.; Modelska, K.; Scardino, P.
Annals of Oncology (2016)

Fulltext@MSK | Save

Atezolizumab (atezo) in platinum (plat)-treated locally advanced/metastatic urothelial carcinoma (mUC): Updated OS, safety and biomarkers from the Ph II IMvigor210 study

Meeting Abstract

Loriot, Y.; Rosenberg, J. E.; Powles, T. B.; Necchi, A.; Hussain, S.; Morales, R.; Retz, M.; Niegisch, G.; Duran, I.; Theodore, C.; more...
Annals of Oncology (2016)

Fulltext@MSK | Save

Updated results from a phase I study of nivolumab (nivo) in combination with ipilimumab (ipi) in metastatic renal cell carcinoma (mRCC): The CheckMate 016 study

Meeting Abstract

Hammers, H.; Plimack, E. R.; Infante, J. R.; Rini, B. I.; McDermott, D.; Lewis, L.; Voss, M. H.; Sharma, P.; Pal, S. K.; Razak, A.; more...
Annals of Oncology (2016)

Fulltext@MSK | Save

Evaluation of the novel "trial within a trial" design of METEOR, a randomized phase 3 trial of cabozantinib versus everolimus in patients (pts) with advanced renal cell carcinoma (RCC)

Meeting Abstract

Hessel, C.; Mangeshkar, M.; Motzer, R. J.; Escudier, B.; Powles, T. B.; Schwab, G.; Choueiri, T. K.
Annals of Oncology (2016)

Fulltext@MSK | Save

Insomnia prevalence in an oncology patient population: An Irish tertiary referral centre experience

Meeting Abstract

Harrold, E. C.; Idris, A. F.; Keegan, N. M.; Corrigan, L.; Teo, M. Y.; Lim, S. T.; Duff, E.; Donnell, M. O.; Kennedy, J.; O'Donnell, D.; more...
Annals of Oncology (2016)

Fulltext@MSK | Save